Asia · Regional markets · The Financial Express

Cancer drug price cap: Hospitals face up to 3% EBITDA impact, says JM Financial

Published by The Financial Express · India 8 h ago

Cancer drug margin caps may cut hospital EBITDA by 1.5-3%, while lowering patient costs from Nov. 9; see what changes for hospitals.

Read the full article on The Financial Express Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.financialexpress.com)

Also worth reading

Eternal share: What to expect from Zomato parent’s Q2 results 2026 as Blinkit growth stays strong

The Straits Times Business

Monetary policy could turn accommodative as AI productivity gains take hold: MAS chief economist

The Business Times

Faster delivery, easier credit fuel South-east Asia e-commerce: survey

Business Standard

Artha Bharat to shift two GIFT City funds to Abu Dhabi over tax hurdles

Mapping China’s biotech titans

Pulse (Maeil Business)

SEVENTEEN leads Asia tour revenue with $97mn